NF2 and meningioma: Furthermore, we show that monoclonal formation can be observed in both NF2-loss and non-NF2 mutant tumors and those meningiomas can undergo branched evolution to display intertumoral heterogeneity in the same patient (Figs. 2c, 3c, 4c).